Completed OBSERVATIONAL NCT00760669

An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants

Post Marketing Surveillance of Remicade in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Patients

Sponsor: Janssen Korea, Ltd., Korea

Conditions Arthritis, Psoriatic Arthritis, Rheumatoid Psoriasis Spondylitis, Ankylosing

Interventions Infliximab; observational study Methotrexate; observational study

Updated 7 times since 2017 Last updated: Sep 25, 2013 Started: May 31, 2007 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Arthritis, Psoriatic and Arthritis, Rheumatoid, this trial is completed. The trial is conducted by Janssen Korea, Ltd., Korea and has accumulated 7 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Janssen Korea, Ltd., Korea

Data source: Janssen Korea, Ltd., Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.